The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
Subject of study. Post-authorisation pharmacovigilance enables the continuous updating of knowledge about adverse effects of medicinal products used in everyday clinical practice. As a result, new information emerges that may change the current positive safety assessment of the drug and contributes...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Polish Pharmaceutical Society,
2022-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|